DCF — PORTNEUF MEDICAL CENTER
Enterprise Value: $468.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$468.2M
Enterprise Value
$128.1M
PV of Cash Flows
$340.1M
PV of Terminal Value
$547.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $402.0M | $55.8M | 14.0% | $27.3M | $24.8M |
| Year 2 | $414.1M | $61.6M | 15.0% | $31.2M | $25.8M |
| Year 3 | $426.5M | $67.7M | 16.0% | $35.4M | $26.6M |
| Year 4 | $439.3M | $71.9M | 16.0% | $38.1M | $26.0M |
| Year 5 | $452.5M | $75.2M | 17.0% | $40.1M | $24.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $468.2M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$390.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13369750104769515
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5